HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karen A Tourian Selected Research

Desvenlafaxine Succinate

12/2016Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder.
11/2015Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
5/2015Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.
4/2015Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis.
1/2015Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.
5/2014Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.
3/2013A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder.
2/2013Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial.
1/2013Efficacy and safety of desvenlafaxine 25 and 50▒mg/day in a randomized, placebo-controlled study of depressed outpatients.
9/2012High-dose desvenlafaxine in outpatients with major depressive disorder.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karen A Tourian Research Topics

Disease

26Major Depressive Disorder (Major Depressive Disorders)
12/2016 - 11/2007
2Dizziness (Lightheadedness)
11/2009 - 07/2008
2Hyperhidrosis
11/2009 - 07/2008
2Nausea
11/2009 - 01/2009
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2009 - 07/2008
1Body Weight (Weight, Body)
12/2016
1Hypertension (High Blood Pressure)
04/2015
1Headache (Headaches)
11/2009
1Fatigue
11/2009
1Diarrhea
11/2009
1Erectile Dysfunction
04/2009
1Medically Unexplained Symptoms
01/2009
1Constipation
07/2008
1Social Phobia
11/2007
1Pain (Aches)
11/2007

Drug/Important Bio-Agent (IBA)

26Desvenlafaxine SuccinateFDA Link
12/2016 - 11/2007
5Serotonin (5 Hydroxytryptamine)IBA
04/2015 - 07/2008
5Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2015 - 07/2008
2Antidepressive Agents (Antidepressants)IBA
01/2015 - 04/2009
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
07/2008 - 11/2007
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
01/2010